Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-1459
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Predicting cognitive decline with non-clinical markers in Parkinson’s disease (PRECODE-2) ; day:28 ; month:2 ; year:2019 ; pages:1-8
Journal of neurology ; (28.2.2019), 1-8
- Urheber
-
Yousaf, Tayyabah
Pagano, Gennaro
Niccolini, Flavia
Politis, Marios
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00415-019-09250-y
- URN
-
urn:nbn:de:101:1-2019032520530845187939
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Yousaf, Tayyabah
- Pagano, Gennaro
- Niccolini, Flavia
- Politis, Marios
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
Predicting the onset of freezing of gait in Parkinson’s disease
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
Predicting the onset of freezing of gait in Parkinson’s disease
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease
Non-clinical Pharmacology of YTX-7739: a Clinical Stage Stearoyl-CoA Desaturase Inhibitor Being Developed for Parkinson’s Disease
Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Correction to: Predict cognitive decline with clinical markers in Parkinson’s disease (PRECODE-1)
Reduced sphingolipid hydrolase activities, substrate accumulation and ganglioside decline in Parkinson’s disease
Longitudinal decline in DAT binding in Parkinson’s disease: connections with sleep disturbances
Predicting the onset of freezing of gait in Parkinson’s disease
Association of retinal neurodegeneration with the progression of cognitive decline in Parkinson’s disease
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson’s disease
Differential effects of sex on longitudinal patterns of cognitive decline in Parkinson’s disease
Associations of Body Mass Index-Metabolic Phenotypes with Cognitive Decline in Parkinson’s Disease
Freezing of gait is a risk factor for cognitive decline in Parkinson’s disease
Genetic polymorphisms in the renin-angiotensin system and cognitive decline in Parkinson’s disease